Effectiveness of human adipose tissue-derived mesenchymal stem cells expressing alpha-1 antitrypsin gene in liver fibrosis: a study in mice
Gastroenterology and Hepatology from Bed to Bench,
Vol. 17 No. 2 (2024),
14 April 2024
https://doi.org/10.22037/ghfbb.v17i2.2923
Abstract
Aim: The present study examined the protective potential of human adipose tissue-derived mesenchymal stem cells (hASCs) modified to overexpress alpha-1 antitrypsin (AAT), in a mouse model of the liver fibrosis.
Background: For the treatment of end-stage liver diseases, cell therapy has emerged as a promising noninvasive alternative to liver transplantation. Mesenchymal stem cells (MSCs) are being evaluated due to their dual capabilities of promoting liver regeneration and modulating the pathogenic inflammation of the immune system.
Methods: Liver fibrosis was induced in mice via the intraperitoneal injection of carbon tetrachloride (CCl4). MSCs were extracted from the human adipose tissue. After stemness confirmation, the cells were transduced with the lentiviruses containing the AAT gene, and then injected into the mice’s tail vein. Fourteen days’ post-transplantation, mice were sacrificed, and blood and tissue samples were collected for analysis. Important liver enzymes, including alanine transaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), albumin, and total bilirubin (TB), were measured. Histological studies were carried out using the hematoxylin and eosin (H&E), as well as Masson’s trichrome (MT) staining.
Results: Compared to hASCs, treatment with AAT-hASCs resulted in greater reductions in ALT, AST, ALP, and TB, as well as normalized albumin levels. AAT-hASCs promoted enhanced liver regeneration histologically, likely attributable to anti-inflammatory and anti-proteolytic properties of AAT.
Conclusion: These findings indicate AAT-engineered hASCs as a promising cell-gene therapy candidate for further study in liver cirrhosis models.
- liver fibrosis
- Adipose tissue-derived mesenchymal stem cells
- Alpha-1 antitrypsin
- Lentiviral vectors
- carbon tetrachloride
How to Cite
References
Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Advanced drug delivery reviews 2017; 121:27-42.
Wilkinson HN, Hardman MJ. Wound healing: Cellular mechanisms and pathological outcomes. Open biology 2020; 10:200223.
Schuppan D, Kim YO. Evolving therapies for liver fibrosis. The Journal of clinical investigation 2013; 123:1887-1901.
Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Comprehensive Physiology 2011; 3:1473-1492.
Singal AK, Duchini A. Liver transplantation in acute alcoholic hepatitis: Current status and future development. World journal of hepatology 2011; 3:215.
Ali G, Masoud MS. Bone marrow cells ameliorate liver fibrosis and express albumin after transplantation in CCl4-induced fibrotic liver. Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association 2012; 18:263.
B A, R A, A P, R J. Clinical efficacy of autologous mesenchyme multipotential stem cells transplantation in the liver cirrhosis and portal hypertension treatment. Georgian Med News 2014; 39:45.
El-Ansary M, Abdel-Aziz I, Mogawer S, Abdel-Hamid S, Hammam O, Teaema S, et al. Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Reviews and Reports 2012; 8:972-981.
Takami T, Terai S, Sakaida I. Stem cell therapy in chronic liver disease. Current opinion in gastroenterology 2012; 28:203-208.
Wang Y, Lian F, Li J, Fan W, Xu H, Yang X, et al. Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats. Journal of translational medicine 2012; 10:133.
Zhang L, Ye J-S, Decot V, Stoltz J-F, de Isla N. Research on stem cells as candidates to be differentiated into hepatocytes. Bio-Medical Materials and Engineering 2012; 22:105-111.
Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell transplantation 2016; 25:829-848.
Tan CY, Lai RC, Wong W, Dan YY, Lim S-K, Ho HK. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem cell research & therapy 2014; 5:76.
Samsonraj RM, Raghunath M, Nurcombe V, Hui JH, van Wijnen AJ, Cool SM. Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem cells translational medicine 2017; 6:2173-2185.
Chivukula RR, Mendell JT. Abate and switch: miR-145 in stem cell differentiation. Cell 2009; 137:606-608.
Anjos-Afonso F, Bonnet D. Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood 2006; 109:1298-1306.
in't Anker PS, Scherjon SA, Kleijburg‐van der Keur C, de Groot‐Swings GM, Claas FH, Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem cells 2004; 22:1338-1345.
Davoodian N, Lotfi AS, Soleimani M, Mowla SJ. MicroRNA‐122 overexpression promotes hepatic differentiation of human adipose tissue‐derived stem cells. Journal of cellular biochemistry 2014; 115:1582-1593.
Fiore EJ, Mazzolini G, Aquino JB. Mesenchymal stem/stromal cells in liver fibrosis: recent findings, old/new caveats and future perspectives. Stem Cell Reviews and Reports 2015; 11:586-597.
Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, Alaniz L, et al. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Molecular pharmaceutics 2011; 8:1538-1548.
Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M. Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem cells 2014; 32:2818-2823.
Aquino JB, Bolontrade MF, García MG, Podhajcer OL, Mazzolini G. Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma. Gene Therapy 2010; 17:692-708.
Jung S-C, Park S. New Sources, Differentiation, and Therapeutic Uses of Mesenchymal Stem Cells 2.0. MDPI; 2023. p. 3938.
Stoller JK, Aboussouan LS. α1-antitrypsin deficiency. The Lancet 2005; 365:2225-2236.
Janciauskiene S, Larsson S, Larsson P, Virtala R, Jansson L, Stevens T. Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by α1-antitrypsin. Biochemical and biophysical research communications 2004; 321:592-600.
Janciauskiene SM, Nita IM, Stevens T. α1-Antitrypsin, Old Dog, New Tricks α1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. Journal of Biological Chemistry 2007; 282:8573-8582.
M Hunt J, Tuder R. Alpha 1 anti-trypsin: one protein, many functions. Current molecular medicine 2012; 12:827-835.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet 2012; 380:2095-2128.
Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, et al. α-1 Antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. The American journal of pathology 2006; 169:1155-1166.
Atkinson M, Song S. Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes 2007; 56:13161323Zhou.
Davoodian N, Lotfi AS, Soleimani M, Mola SJ, Arjmand S. Let-7f microRNA negatively regulates hepatic differentiation of human adipose tissue-derived stem cells. Journal of physiology and biochemistry 2014; 70:781-789.
Mohammadpour A, Arjmand S, Lotfi AS, Tavana H, Kabir-Salmani M. Promoting hepatogenic differentiation of human mesenchymal stem cells using a novel laminin-containing gelatin cryogel scaffold. Biochemical and Biophysical Research Communications 2018; 507:15-21.
Gandomani MG, Lotfi AS, Tamandani DK, Arjmand S, Alizadeh S. The enhancement of differentiating adipose derived mesenchymal stem cells toward hepatocyte like cells using gelatin cryogel scaffold. Biochemical and biophysical research communications 2017; 491:1000-1006.
Ghaedi M, SAHEBGHADAM LA, SOLEYMANI M, Shamsara M, Arjmand S, Adibi B. Expression of recombinant alpha-1 antitrypsin in CHO and COS-7 cell lines using lentiviral vector. 2009.
Jang YO, Kim MY, Cho MY, Baik SK, Cho YZ, Kwon SO. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model. BMC gastroenterology 2014; 14:198.
Yang D, Wang ZQ, Deng JQ, Liao JY, Wang X, Xie J, et al. Adipose‐derived stem cells: A candidate for liver regeneration. Journal of digestive diseases 2015; 16:489-498.
Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, et al. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem cells 2008; 26:2705-2712.
D’souza N, Rossignoli F, Golinelli G, Grisendi G, Spano C, Candini O, et al. Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies. BMC medicine 2015; 13:186.
Lou G, Yang Y, Liu F, Ye B, Chen Z, Zheng M, et al. MiR‐122 modification enhances the therapeutic efficacy of adipose tissue‐derived mesenchymal stem cells against liver fibrosis. Journal of cellular and molecular medicine 2017; 21:2963-2973.
Seo KW, Sohn SY, Bhang DH, Nam MJ, Lee HW, Youn HY. Therapeutic effects of hepatocyte growth factor‐overexpressing human umbilical cord blood‐derived mesenchymal stem cells on liver fibrosis in rats. Cell biology international 2014; 38:106-116.
Jin S, Li H, Han M, Ruan M, Liu Z, Zhang F, et al. Mesenchymal stem cells with enhanced Bcl-2 expression promote liver recovery in a rat model of hepatic cirrhosis. Cellular Physiology and Biochemistry 2016; 40:1117-1128.
Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Köhnlein T, Welte T. The discovery of α1-antitrypsin and its role in health and disease. Respiratory medicine 2011; 105:1129-1139.
De Serres F, Blanco I. Role of alpha‐1 antitrypsin in human health and disease. Journal of internal medicine 2014; 276:311-335.
Jedicke N, Struever N, Aggrawal N, Welte T, Manns MP, Malek NP, et al. Alpha‐1‐antitrypsin inhibits acute liver failure in mice. Hepatology 2014; 59:2299-2308.
Jiang F, Stefanovic B. Homeobox Gene Prx1 is expressed in activated hepatic stellate cells and transactivates Collagen α1 (I) promoter. Experimental Biology and Medicine 2008; 233:286-296.
Mohsin S, Shams S, Nasir GA, Khan M, Awan SJ, Khan SN, et al. Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue. Differentiation 2011; 81:42-48.
Ali G, Mohsin S, Khan M, Nasir GA, Shams S, Khan SN, et al. Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis. Journal of translational medicine 2012; 10:75.
- Abstract Viewed: 279 times
- PDF Downloaded: 113 times